[BEC] Bio Engineering Capital acquires medical AI media “The Medical AI Times” *BEC*
Press release: September 4, 2024
**
Bio Engineering Capital acquires medical AI media “The Medical AI Times” *~Strengthening the media business with the aim of developing the medical AI/DX industry and supporting researchers and entrepreneurs~* Bio Engineering Capital Co., Ltd. (Headquarters: Chuo-ku, Tokyo, Representative Director: Yuki Shimabara, hereinafter “BEC”) is a medical AI media company “The
The Medical AI Times Co., Ltd. (Headquarters: Shibuya-ku, Tokyo, Representative Director: Yamaba)
Yasuhiro (hereinafter referred to as “The Medical AI Times”) acquired 75% of the shares and made it a subsidiary.
“The Medical AI
The Times is a news media specializing in medical AI, and provides the latest information on AI utilization cases in the medical field overseas in cooperation with active doctors and researchers. BEC has made this acquisition because we believe that not only support for entrepreneurs but also educational activities by disseminating information through specialized media are important for the
development of the medical AI industry. In the future, “The
Medical AI
We plan to strengthen the media business of “Times” and feature cutting-edge research and development cases such as medical AI, as well as interviews with researchers and entrepreneurs related to medical AI. BEC will strengthen awareness activities in the medical AI field and contribute to the development of the medical AI industry by disseminating information through specialized media.
* [About The Medical AI Times] *
A specialized news media specializing in medical AI and medicine that utilizes AI. Written and supervised by active doctors and researchers, it mainly provides the latest information on examples of AI
utilization in the medical field overseas and trends in medical AI startups and ventures.
URL: https://aitimes.media/
* [Comment from Editor-in-Chief Masaki Okamoto] *
“The Medical A.I.
The Times is a specialized media specializing in the field of medical technology, created with the aim of “communicating information on cutting-edge medical science and technology that utilizes AI to citizens in an easy-to-understand manner.” Supported by more than 13,000 enthusiastic subscribers, until now we have been managing the business on an individual basis with a limited number of members. Engineering
With the strong support of Capital, we had the opportunity to make a big leap forward. We will significantly strengthen our writing and management structure and provide valuable content such as the latest trends in medical AI technology mainly from overseas. Thank you for your continued support. ”
Career: Graduated from Shinshu University School of Medicine (MD), completed the professional degree program at the University of Tokyo (MPH), completed the doctoral program at the University of Tokyo Graduate School of Medicine (PhD), University College London (UK) College London) Completed Master of Science with distinction (MSc with distinction). UCL visiting
After working as researcher, Japan Society for the Promotion of Science Special Researcher, and University of Tokyo Specially Appointed Researcher, The Medical AI
Co-founded Times Co., Ltd. Then Boston Medical
Founded Sciences, Inc. and worked on research and development and clinical implementation of the non-laxative virtual endoscopy system “AIM4CRC” (currently CEO). In addition, he is a lecturer in radiology at Harvard Medical School, and a 3D professor at Massachusetts General Hospital.
He also serves as a researcher at Imaging Research and a visiting professor at SBI Graduate School.
* [Comment from Shimabara, Representative Director of Bio Engineering Capital Co., Ltd.] *
“This time, as a medical AI business operator, I have read The Medical AI, which I have loved for many years.
I am honored to have such a wonderful relationship with the Times. While maintaining the high-quality content that Editor-in-Chief Okamoto has built, we will strive to deliver more diverse and rich articles. Furthermore, we would like to share the thoughts of medical professionals, researchers, and entrepreneurs who are taking on the challenges at the forefront of medical AI, and grow into a media that generates emotion, empathy, and resonance through medical AI. BEC will continue to strengthen its media business with the aim of developing the medical AI/DX industry. ”